HGP-30 shows significantly increased level of protection in SCID mouse test
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
1996 |
|---|---|
| Erschienen: |
1996 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
AIDS patient care and STDs - 10(1996), 3 vom: 15. Juni, Seite 190-1 |
| Sprache: |
Englisch |
|---|
| Anmerkungen: |
Date Completed 24.04.1997 Date Revised 20.11.2014 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM112676278 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM112676278 | ||
| 003 | DE-627 | ||
| 005 | 20231222162249.0 | ||
| 007 | tu | ||
| 008 | 231222s1996 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0376.xml |
| 035 | |a (DE-627)NLM112676278 | ||
| 035 | |a (NLM)11361639 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a HGP-30 shows significantly increased level of protection in SCID mouse test |
| 264 | 1 | |c 1996 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 24.04.1997 | ||
| 500 | |a Date Revised 20.11.2014 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Clinical Trial | |
| 650 | 4 | |a Clinical Trial, Phase I | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a News | |
| 650 | 7 | |a AIDS Vaccines |2 NLM | |
| 650 | 7 | |a Epitopes |2 NLM | |
| 650 | 7 | |a HGP-30 peptide, Human immunodeficiency virus-1 |2 NLM | |
| 650 | 7 | |a HIV Antigens |2 NLM | |
| 650 | 7 | |a Peptides |2 NLM | |
| 650 | 7 | |a gag Gene Products, Human Immunodeficiency Virus |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t AIDS patient care and STDs |d 1996 |g 10(1996), 3 vom: 15. Juni, Seite 190-1 |w (DE-627)NLM09547725X |x 1557-7449 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:1996 |g number:3 |g day:15 |g month:06 |g pages:190-1 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 1996 |e 3 |b 15 |c 06 |h 190-1 | ||